ArticlePhysics and imaging in radiation oncology2024
Automated plan generation for prostate radiotherapy patients using deep learning and scripted optimization.
Article in Physics and imaging in radiation oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Artificial Intelligence (AI)-based tools in the diagnosis and management of prostate cancer: a systematic review and meta-analysis.Prostate cancer and prostatic diseases · 2026Pooled it
- Interpretable graph-conditioned CNNs for dose-volume histogram prediction in radiotherapy.Medical physics · 2026Article
- A rule-based, feedback-driven framework for fully automated prostate VMAT planning.Journal of applied clinical medical physics · 2026Article
- Objective-function-guided automated VMAT planning reduces OAR dose, low-dose exposure, and inter-planner variability in breast radiotherapy.Scientific reports · 2026Article
- A deep learning-driven automated treatment planning framework for cervical cancer patients treated with volumetric modulated arc therapy.Radiation oncology (London, England) · 2026Article
- Dosimetric benefits of half-field arc in prostate cancer treatment.Physical and engineering sciences in medicine · 2026Article
- Ultra-fast, one-click radiotherapy treatment planning outside a treatment planning system.Physics and imaging in radiation oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Purpose: Treatment planning is a time-intensive task that could be automated. We aimed to develop a "single-click" workflow, fully deployed within a commercial treatment planning system (TPS), for autoplanning prostate radiotherapy treatment plans using predictions from a deep learning model (DLM). Materials and Methods: Automatically generated treatment plans were created with a single script, executed from within a commercial TPS scripting environment, that performed two stages sequentially. Initially, a 3D dose distribution was predicted with a ResUNet DLM. The DLM was trained and validated using previously treated datasets (n = 120) which used 3D contours as inputs. Following this, dose predictions were converted into treatment plans by extracting dose-volume metrics from the predictions to use as objectives for the inverse optimizer within the TPS. An independent test dataset (n = 20) was used to evaluate the similarity between automated and clinical plans. Results: For planning target volumes, the median percentage difference and interquartile range between the automatically generated plans and clinical plans were 0.4% [0.2-1.1%] for the V Conclusions: An automatic plan generation workflow that uses a DL model with scripted optimization was fully deployed in a commercial TPS. Autoplans were compared to previously treated clinical plans and were found to be non-inferior.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.